In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against <i>S. mansoni</i> Infection in Preclinical Murine Models
This study aimed to develop and assess the long-term stability of drug-loaded solid lipid nanoparticles (SLNs). The SLNs were designed to extend the release profile, overcome the problems of bioavailability and solubility, investigate toxicity, and improve the antischistosomal efficacy of praziquant...
Main Authors: | Tayo A. Adekiya, Pradeep Kumar, Pierre P. D. Kondiah, Philemon Ubanako, Yahya E. Choonara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/16/9485 |
Similar Items
-
Comparative randomised trial of high and conventional doses of praziquantel in the treatment of schistosomiasis mansoni
by: Leonardo C de Queiroz, et al.
Published: (2010-07-01) -
Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection
by: Omary Mashiku Minzi, et al.
Published: (2021-04-01) -
Optimized Nanostructured Lipid Carriers Integrated into in situ Nasal Gel for Enhancing Brain Delivery of Flibanserin [Retraction]
by: Fahmy UA, et al.
Published: (2023-04-01) -
In Vivo Evaluation of an Antibody-Functionalized Lipoidal Nanosystem for Schistosomiasis Intervention
by: Tayo A. Adekiya, et al.
Published: (2022-07-01) -
Development of Praziquantel sulphonamide derivatives as antischistosomal drugs
by: Andrea Angeli, et al.
Published: (2022-12-01)